Biomerica Inc - Asset Resilience Ratio

Latest as of August 2021: 1.44%

Biomerica Inc (BMRA) has an Asset Resilience Ratio of 1.44% as of August 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Biomerica Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets

$165.32K
Cash + Short-term Investments

Total Assets

$11.52 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1999–2018)

This chart shows how Biomerica Inc's Asset Resilience Ratio has changed over time. See net assets of Biomerica Inc for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Biomerica Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Biomerica Inc market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $165.32K 1.44%
Total Liquid Assets $165.32K 1.44%

Asset Resilience Insights

  • Limited Liquidity: Biomerica Inc maintains only 1.44% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Biomerica Inc Industry Peers by Asset Resilience Ratio

Compare Biomerica Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 3.37%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
Medical Devices 54.67%
Universus Photo Imagings Limited
NSE:UNIVPHOTO
Medical Devices 30.97%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%
Heramed Ltd
AU:HMD
Medical Devices 0.83%
Acarix A/S
ST:ACARIX
Medical Devices 37.81%

Annual Asset Resilience Ratio for Biomerica Inc (1999–2018)

The table below shows the annual Asset Resilience Ratio data for Biomerica Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2018-05-31 0.00% $0.00 $5.22 Million --
2017-05-31 0.00% $0.00 $5.02 Million --
2016-05-31 0.00% $0.00 $5.73 Million --
2015-05-31 0.00% $0.00 $6.12 Million --
2014-05-31 0.00% $0.00 $6.47 Million --
2013-05-31 0.00% $0.00 $6.39 Million --
2012-05-31 0.00% $0.00 $5.57 Million --
2009-05-31 1.94% $100.00K $5.15 Million +1.93pp
2008-05-31 0.01% $355.00 $5.11 Million -0.01pp
2007-05-31 0.02% $532.00 $3.22 Million -0.12pp
2006-05-31 0.14% $3.28K $2.43 Million -0.01pp
2005-05-31 0.14% $8.18K $5.79 Million -0.33pp
2004-05-31 0.47% $26.12K $5.57 Million +0.23pp
2003-05-31 0.24% $13.11K $5.55 Million +0.19pp
2002-05-31 0.05% $2.53K $5.28 Million -0.73pp
2001-05-31 0.78% $41.57K $5.35 Million -0.69pp
2000-05-31 1.47% $98.77K $6.74 Million +0.18pp
1999-05-31 1.28% $100.00K $7.80 Million --
pp = percentage points

About Biomerica Inc

NASDAQ:BMRA USA Medical Devices
Market Cap
$6.46 Million
Market Cap Rank
#27863 Global
#5505 in USA
Share Price
$2.19
Change (1 day)
+0.46%
52-Week Range
$1.92 - $4.14
All Time High
$16.00
About

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more